Agilent Technologies Inc Stock Price, News & Analysis

Agilent Technologies announced plans to showcase new laboratory equipment at HPLC 2025 in Bruges, Belgium. The company will introduce their new Hybrid Multisampler and LC Single Quadrupole Mass Spectrometers. The InfinityLab Pro iQ Series features enhanced sensitivity for analyzing oligonucleotides, therapeutic peptides, and proteins, with real-time status feedback and mass-based fraction collection capabilities. The eco-friendly system has earned MyGreenLab ACT EcoLabel 2.0 certification. The 1290 Infinity III Hybrid Multisampler offers both traditional flow-through and Feed Injection Mode, reducing sample preparation time and ensuring better peak shapes. Early adopters like Novopor Advanced Science report significant workflow improvements, praising the system's robustness, reproducibility, and user-friendly interface. Agilent will also preview a new fluorescence detector and showcase enhanced serviceable flow cells and expanded Bio Core offerings.

Crawford & Company (NYSE: CRD-A and CRD-B) has appointed Amy Shore as an independent director effective June 6, 2025, expanding their board to ten directors, including three women. Shore brings over 30 years of leadership experience in financial services, most recently serving as chief transformation officer at Nationwide Insurance. In her previous role as chief customer officer, she managed customer strategy for a $60B enterprise serving 14 million customers. Shore holds a bachelor's degree from Bowling Green State University, where she currently serves as board chair, and has completed executive programs at Northwestern's Kellogg School and UC Berkeley. A 2023 finalist for 50/50 Women on Boards' "50 Women to Watch for Boards," Shore's expertise in business transformation, customer experience, and operational excellence is expected to contribute to Crawford's strategic growth.

TORM plc has announced a capital increase through the issuance of 11,236 A-shares, with a nominal value of USD 112.36, as part of its incentive program involving Restricted Share Units. The new shares were subscribed for in cash at DKK 0.08 per A-share and will carry the same rights as existing ordinary shares, including dividend rights from the issuance date. Following this capital increase, TORM's total share capital stands at USD 979,524.31, consisting of 97,952,429 A-shares, one B-share, and one C-share, all with a nominal value of USD 0.01 each. The A-shares carry a total of 97,952,429 votes, while the B and C shares have specific voting rights.

TORM (TRMD) has acquired the remaining 25% stake in ME Production (MEP), a Danish industrial engineering company specializing in green maritime equipment, gaining full ownership after initially acquiring 75% in 2022. The companies have collaborated since 2018, with MEP installing over 70 exhaust gas cleaning systems on TORM vessels. MEP will maintain its independence and headquarters in Frederikshavn, Denmark. Through their partnership, TORM achieved a 40% reduction in CO₂ intensity compared to 2008, surpassing IMO's 2030 target by six years. MEP's key innovations include heat pump systems for reducing energy use in ships and industrial facilities. As sole owner, TORM will provide enhanced strategic support and investment to accelerate MEP's growth as an innovation center for clean maritime technologies.

Agilent Technologies (NYSE: A) reported strong Q2 FY2025 financial results with revenue of $1.67 billion, representing 6.0% reported growth and 5.3% core growth year-over-year. The company's GAAP net income was $215 million ($0.75 EPS), down 29% from Q2 2024, while non-GAAP net income reached $373 million ($1.31 EPS), up 7%. By segment, Life Sciences and Diagnostics Markets Group revenue grew 8% to $654 million, Agilent CrossLab Group increased 7% to $713 million, while Applied Markets Group declined 1% to $301 million. For FY2025, Agilent projects revenue between $6.73-6.81 billion (3.4-4.6% growth) and non-GAAP EPS of $5.54-5.61. Q3 outlook expects revenue of $1.645-1.675 billion with non-GAAP EPS of $1.35-1.37.

Agilent Technologies (NYSE: A) has appointed August Specht, Ph.D. as its new Chief Technology Officer, effective June 9, 2025. Specht joins Agilent from Thermo Fisher Scientific, where he served as vice president of Global R&D for the Chromatography and Mass Spectrometry Division. With over 25 years of experience in analytical instruments, software, and consumables development, Specht brings extensive expertise in R&D, product management, strategy, and business development from his roles at Thermo Fisher and Varian Instruments.

Specht holds a B.S. in Chemistry from Queen's University, a Ph.D. in Analytical Chemistry from the University of British Columbia, and an MBA from UC Berkeley. Agilent, a global leader in analytical and clinical laboratory technologies, reported revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide.

Agilent Technologies (NYSE: A) has announced significant enhancements to its 8850 Gas Chromatograph (GC), now featuring compatibility with single and triple quadrupole mass spectrometry (MS) systems. The upgraded system stands out as one of the fastest and smallest benchtop GC/MS available, delivering up to 300°C/min oven ramp rates and fast cool-down times.

Key improvements include increased temperature range, compatibility with CTC PAL3 Series 2 Autosampler Systems, Multi-Mode Inlet (MMI), and backflush capabilities. The system achieves 45% less power usage compared to other benchtop GC systems, supporting sustainability goals while maintaining high performance. When integrated with 5977C, 7000E, or 7010D MS systems, it provides enhanced molecular identification and quantification capabilities for chemicals, energy, food, environmental, and forensic laboratories.

Agilent Technologies has launched the InfinityLab Pro iQ Series, a next-generation liquid chromatography-mass detection system. The series includes two models: the InfinityLab Pro iQ and Pro iQ Plus, designed for analyzing therapeutic molecules, oligonucleotides, peptides, and proteins. The Pro iQ Plus features an expanded mass range of m/z 2-3,000 and enhanced sensitivity through Agilent Jet Stream technology, while the Pro iQ system offers a mass range of m/z 2-1,600 for small molecule analysis. These systems serve diverse markets including pharmaceutical, biopharmaceutical, academic research, environmental testing, and food safety sectors. The technology enables mass confirmation, impurity profiling, biomolecule characterization, trace contaminant detection, and compound purification with greater specificity than traditional UV detection.

TORM plc (TRMD) has announced the completion of two significant corporate actions following approval from the High Court of Justice in England and Wales. The company executed a USD 180 million capital reduction from its share premium account and cancelled 493,371 A-shares previously held as Treasury Shares. Following these actions, TORM's share capital now stands at USD 979,411.95, consisting of 97,941,193 A-shares, one B-share, and one C-share, all with a nominal value of USD 0.01 each. The capital reduction does not involve any distribution or payment of capital and does not change the nominal value of shares. These corporate actions were previously approved by shareholders at the Annual General Meeting held on April 16, 2025.